Stereotaxis

About:

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.

Website: http://www.stereotaxis.com

Twitter/X: STXSontheRoad

Top Investors: Redmile Group, Advantage Capital, Stifel Financial, Ascension Ventures, Alafi Capital

Description:

Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

Total Funding Amount:

$108M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

1990-01-01

Contact Email:

ROW(AT)stereotaxis.com

Founders:

Robert McNeil

Number of Employees:

51-100

Last Funding Date:

2024-08-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai